Next Article in Journal
Comparison of the Neuroprotective Effects of Aspirin, Atorvastatin, Captopril and Metformin in Diabetes Mellitus
Previous Article in Journal
Electrostatics of Tau Protein by Molecular Dynamics
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Communication

Structure and Ligands Interactions of Citrus Tryptophan Decarboxylase by Molecular Modeling and Docking Simulations

1
Consiglio Nazionale delle Ricerche (CNR), Istituto di Scienze dell’Alimentazione (ISA), 83100 Avellino, Italy
2
CNR, Istituto di Bioscienze e BioRisorse (IBBR), 70126 Bari, Italy
3
Dipartimento di Medicina di Precisione, Università degli Studi della Campania “Luigi Vanvitelli”, 80138 Napoli, Italy
4
Stazione Sperimentale per le Industrie delle Essenze e dei Derivati dagli Agrumi (SSEA), Azienda Speciale della Camera di Commercio di Reggio Calabria, 89125 Reggio Calabria, Italy
5
CNR, IBBR, 80055 Portici, Italy
*
Authors to whom correspondence should be addressed.
Biomolecules 2019, 9(3), 117; https://doi.org/10.3390/biom9030117
Submission received: 29 December 2018 / Revised: 25 February 2019 / Accepted: 22 March 2019 / Published: 26 March 2019

Abstract

:
In a previous work, we in silico annotated protein sequences of Citrus genus plants as putative tryptophan decarboxylase (pTDC). Here, we investigated the structural properties of Citrus pTDCs by using the TDC sequence of Catharanthus roseus as an experimentally annotated reference to carry out comparative modeling and substrate docking analyses. The functional annotation as TDC was verified by combining 3D molecular modeling and docking simulations, evidencing the peculiarities and the structural similarities with C. roseus TDC. Docking with l-tryptophan as a ligand showed specificity of pTDC for this substrate. These combined results confirm our previous in silico annotation of the examined protein sequences of Citrus as TDC and provide support for TDC activity in this plant genus.

Graphical Abstract

1. Introduction

Plant natural defense mechanisms attract considerable interest of low-input and sustainable agriculture for crops protection [1]. Aromatic l-amino acids (AA) are precursors of secondary metabolites with defensive roles [2]. The decarboxylation of l-tryptophan and l-tyrosine by specific decarboxylases, dependent on pyridoxal-5′-phosphate (PLP) as a cofactor (vitamin B6 derivative), is essential for the production of the respective aromatic amines tryptamine and tyramine [3]. In plants, AA decarboxylases (AADC) evolved significant differences in their substrate selectivity, distinguishing between indole and phenol side chains. Plant l-tryptophan decarboxylase (TDC) is a highly specific lyase (EC 4.1.1.28, formerly EC 4.1.1.27) that exclusively catalyzes the decarboxylation of l-tryptophan and l-5-OH-tryptophan [4]. In fact, TDC does not recognize as substrates phenolic l-amino acids and their derivatives, which instead are specifically recognized by the plant l-tyrosine decarboxylase (TYDC) [5]. Animal AADC admits a broad spectrum of substrates, such as l-5-OH-tryptophan and 3,4-dihydroxy-l-phenylalanine (l-DOPA, used in Parkinson’s disease treatment), and is better known as l-DOPA decarboxylase (DDC) [6].
Both the TDC gene and the enzyme have been characterized in the rosy periwinkle of Madagascar, Catharanthus roseus (L.) G. Don, where TDC is composed of two identical subunits (homodimer) encoded by a single-copy gene without intron sequences [4,7,8]. In this medicinal plant, tryptamine is a building block for the monoterpenoid indole alkaloids, including natural anticancer agents, such as vinblastine [3]. Various plants, animals, and fungi contain N-methylated and/or 5-hydroxylated forms of tryptamine that are called monoamine alkaloids o indole alkylamines and are commonly known as “tryptamines” [9]. Several tryptamines are known to induce alteration of consciousness in humans, acting as neurotransmitters or neuromodulators of synaptic transmission [9,10]. Tryptamines were also identified in food plants, such as Citrus genus species [11,12]. Our more recent findings showed TDC activity in Citrus spp. and in silico identified the candidate protein sequences of TDC in Citrus genome [2]. Since alterations of the DDC activity can be associated to neurodegenerative and hypertensive diseases, human and animal DDC have been studied in depth and characterized also from the structural point of view [6,13,14]. On the basis of sequence and secondary structure similarities between animal and plant AADC, an analogous catalytic mechanism was proposed [3,7,13].
Alexander et al. [14] and Sandmeier et al. [15] proposed four groups of amino acid decarboxylases, on the basis of sequence comparison, including AADC into group II. The classification of PLP enzymes evidenced a narrow structural diversity [16]. The PLP enzyme superfamily was subdivided by similarity of primary and secondary structures into five main fold types. Schneider et al. [17] updated and confirmed the structural classification into five PLP-binding folds. Decarboxylases were included into two fold types: group I, II, and III decarboxylases share the PLP-binding motif of fold-type I; fold-type III includes group IV decarboxylases. AADC belong to the group II of fold-type I of aspartate aminotransferase family (alpha family). Efforts to elucidate the structure, precise catalytic mechanism, and substrate specificity of plant AADC are in progress, but the origins of the highly selective substrate specificity of TDC are still unknown [2,3,13].
Plant TDC are challenging to identify through amino acid sequences comparison because of their subtle sequence divergence from AADC [13]. However, because the function of TDC is closely related to its extreme substrate selectivity, differentiation on the base of sequence could be an important advance. The difference in substrate specificity within plant AADC is the result of little, but significant, amino acid variations [2,3,18,19]. Recently, TDC activity was converted to TYDC and vice versa by a single amino acid substitution into the active site [13].
Despite the fact that experimental research is needed to obtain highly accurate functional assignments for metabolic functions and substrate specificity, protein annotations can be sufficiently rigorous if based on in silico data mining and verification of their accuracy. With the aim of identifying structural signatures to confirm the previously proposed in silico functional annotation as TDC of the Citrus candidate sequences [2], the present study produced molecular models and substrate docking simulations of the Citrus candidate TDC by a computational biology approach, starting from the 3D models of DDC available in human and animals. Analysis of the models for the properties of substrate and PLP binding sites identified the amino acids involved in ligand interaction. The results are in agreement with experimental evidence described in the literature related to the role of given amino acids in homologous sequences, providing novel insights into the structure–function relationships of TDC enzymes.

2. Materials and Methods

2.1. Comparative Protein Structure Modeling of C. roseus TDC and Citrus pTDCs

The TDC enzyme sequence of C. roseus (UniProtKB/Swiss-Prot accession no. P17770) was retrieved from the NCBI database (www.ncbi.nlm.nih.gov) and consists of 500 amino acids deduced in silico from nt 70 to nt 1572 of the 1740 nt coding sequence (GenBank accession no. M25151 and J04521) [7]. The putative TDC (pTDC) sequences of clementine (Citrus clementina) cultivar Clemenules and sweet orange (Citrus sinensis) cultivar Ridge Pineapple consist of 499 amino acids when translated in silico; they were retrieved from the NCBI database with GenBank accession no. ESR60648 (CICLE_v10014992mg) and KDO55801 (CISIN_1g010842mg), respectively (Ciclev10014992m and orange1.1g010842m in De Masi et al. [2]).
Molecular modeling of the TDCs from C. roseus and Citrus species sequences identified by a previous research [2], was performed according to the procedures reported in previous papers [20,21]. In brief, comparative (homology) modeling was applied on the basis of the crystallographic structure templates of human DDC [6]. This protein is available in the UniProt database (www.uniprot.org) with sequence accession no. P20711 and in the Protein Data Bank (PDB, www.rcsb.org) with three structures, i.e., 3RBF in the apo form with PLP not covalently bound to A chain, 3RBL in the apo form without PLP, and 3RCH in the open conformation with L-peptide linking (LLP) and PLP bound to the A and B chains, respectively. Among the amino acid sequences of DDCs whose structures are available in PDB, human DDC proved to be the most similar to C. roseus TDC and selected Citrus pTDC sequences, as obtained with BLAST search. Their alignment showed also similarity levels suitable for applying comparative modeling, having more than 40% sequence identity and nearly complete sequence coverage. The structure of 3RBF, in the apo form with PLP not covalently bound, was used to model the monomers of TDC proteins. In addition, models of the interaction between Citrus pTDCs with carbiDOPA inhibitor were similarly created by using the template structure of Sus scrofa DDC [18], for which the 1JS3 and 1JS6 structures with and without the inhibitor are available in PDB. Although a little lower than for human DDC, sequence identity and alignment coverage with plant TDCs make this protein also suitable for applying comparative modeling procedures.
Multiple sequence alignments were created by means of the MView tool [22]. Then, the derived alignment of template and target sequences was used as input for MODELLER 9.10 available at www.salilab.org [23]. With the aim of selecting the most reliable model for each Citrus pTDC, we generated 10 structural models for each sequence on the basis of stereochemical and energetic data quality, checked by means of PROCHECK [24] and PROSA [25] programs, respectively. The final models were examined with DiscoveryStudio (Dassault Systèmes, Vélizy-Villacoublay, France).

2.2. Ligands Docking of Citrus pTDC

Docking simulations for the substrate Trp with the best 3D model of each Citrus pTDC, obtained in the previous step, were performed with AutoDock4.0 [26] in order to evaluate the ligand interaction with the enzyme binding site. The ligand was docked in the proposed binding pocket [6], and the software searched for the best interactions between the possible conformations of the substrate and the 3D regions of interest. LigPlot+ [27] was used for investigating in detail the interaction region and creating schematic images of the binding site. Moreover, LigPlot+ was used to analyze the interaction of the carbiDOPA–PLP adduct with sweet orange and clementine pTDC, as modeled on the basis of the PDB template 1JS3 crystallographic structure of S. scrofa DDC (see paragraph 2.1).

3. Results and discussion

3.1. Structure Prediction of TDCs from C. roseus and Citrus by Comparative Modeling

Since animal DDC have shown high sequence similarity to plant TDC [7], we used the crystallographically solved structures of human DDC as a template to model the unknown 3D structure of C. roseus TDC monomer by comparative protein modeling (Supplementary Figure S1). The protein of C. roseus is annotated as TDC regarding its substrate specificity [7], so its model was our reference to be used for comparison with Citrus pTDC which has no experimental annotation.
Then, we performed a multiple sequence alignment of Citrus pTDCs with human DDC (Figure 1) and applied the same procedure of comparative modeling. The two Citrus pTDC subunit sequences are different in one amino acid residue (position 383), evidencing close evolutionary relationships. Schematic views of the obtained 3D models of sweet orange and clementine pTDCs are shown in Figure 2 and Supplementary Figure S2, respectively.
Checking the models for their quality, we obtained energy profiles and Z-score similar to or better than those of the template structure (see Supplementary Figures S3–S6 and Table S1). Comparative modeling is based on the assumptions that structural similarity matches to functional similarity and that folding of homologous proteins is better conserved than their amino acid sequences; thus, this has been a successful approach [28].
Models of C. roseus TDC and Citrus pTDCs appear suitable to structural classification in the CATH-Gene3D database [29] for pig and human DDCs [6,18]. The whole architecture of each Citrus pTDC subunit consists of three main domains (Figure 2 and Supplementary Figure S2). The first is classified in CATH as 1.20.1340.10 (DOPA decarboxylase, N-terminal domain). It shows the presence of three α-helices, with the up-down bundle architecture of the main alpha structural class. The central domain of the sequence is classified in CATH as 3.40.640.10 (Type I PLP-dependent aspartate aminotransferase-like major domain). It folds as a β-sheet formed by seven strands (six parallel and one antiparallel) surrounded by five α-helices, with α-β sandwich architecture. The last domain is classified in CATH as 3.90.1150.10 (aspartate aminotransferase, domain 1) and consists of a smaller β-sheet, formed by four antiparallel strands, alternated by three α-helices. Few additional helices and short strands are also visible along the whole structure. The association of these secondary structures, known as α/β fold, is similar to what observed in human and animal DDCs [6,18,19].
The models result in agreement with the structural properties expected for TDCs, so we used them for simulations of docking with Trp and PLP in order to gain more information and obtain confirmation of the binding site properties and amino acids involved.

3.2. Ligand Binding to TDCs from C. roseus and Citrus by Molecular Docking

We simulated the docking with l-tryptophan and the cofactor PLP of the two Citrus pTDCs and of the C. roseus TDC model to verify the suitability of binding of the Citrus pTDC active site with the substrate Trp (see “Materials and methods” section for details of the procedure). Moreover, because of the availability of a model of pig DDC complexed with carbiDOPA–PLP adduct, we also modeled the sweet orange pTDC with this ligand. A previous TDC comparison, based on amino acid sequence alignments from plant and animal kingdoms, showed high similarity in sequence and structural motifs, demonstrating a remarkable degree of sequence conservation, in spite of the minor substrate selectivity of animal DDC [3,7]. Figure 3 shows the amino acid residues of the sweet orange pTDC binding pocket involved in the interaction with the substrate Trp and the cofactor PLP according to the results of molecular docking simulations. The simulation results for clementine pTDC are shown in Supplementary Figure S7. The analysis of C. roseus TDC binding to l-tryptophan was also performed (Supplementary Figure S8), showing the same amino acid residues as those of Citrus pTDC interacting with Trp in the docking simulations in Figure 3 and Supplementary Figure S7. The 3D views of the binding pocket and ligands in sweet orange and clementine pTDCs are shown in Supplementary Figures S9 and S10, respectively. We also superimposed the model of sweet orange pTDC docked to Trp on the human DDC structure to evidence the high similarity of protein backbone trace and PLP orientation between model and template (Supplementary Figure S11). Figure 4 shows the interaction of the carbiDOPA–PLP adduct with sweet orange pTDC.
To compare the corresponding amino acids in the 3D models, we listed in Table 1 the residues participating to the interaction with ligands according to our simulations (Figure 3 and Figure 4, Supplementary Figures S7 and S8). In addition, the corresponding amino acid residues observed in TYDCs are reported in the last column of Table 1 (based on the multiple alignment of Supplementary Figure S5 from De Masi et al. [2]). This comparison may be useful to check what residues, potentially involved in ligand interaction, appear conserved or different between plant TDCs and TYDCs. As a general overview, there are several amino acids involved in the interaction with ligands; in fact, some difference is observed when Trp or carbiDOPA is used as a ligand, due to their different structure and steric hindrance. Several amino acids, demonstrated as interacting with ligands as reported in Table 1, belong to the four signatures we evidenced in a previous work [2].

3.3. Citrus pTDC Residues Conserved and Involved in Ligand Binding

The first amino acid W87, as indicated in Table 1, interacts with carbiDOPA–PLP in the sweet orange pTDC model (Figure 4) and is part of a conserved motif in TDCs and TYDC. In fact, the segment T85[H/N]W[L/M]SP (motif I) is well conserved in TDC proteins with only few differences, reported in brackets. This small motif seems to be able to discriminate TDC from TYDC. The corresponding sequence T139HWQSP appears strongly conserved among all TYDC sequences retrieved (Supplementary Figure S5 in De Masi et al. [2]). Within this motif, the discriminating amino acid is the conserved glutamine (Q142) in TYDC, even if this residue does not appear to be directly involved in the interaction with ligands. Nevertheless, this difference is interesting, because glutamine has a polar side chain, while leucine/methionine of TDC have non-polar side chains, suggesting their affinity for Tyr or Trp, respectively. This motif was evidenced in reference [2], and the docking simulation offered further details about its possible role in substrate specificity.
The three amino acids F96, P97, and A98 are components of the segment F96PATVSSAAF (motif II), previously evidenced in TDC, and interact with carbiDOPA–PLP in the sweet orange pTDC model (Figure 4). At the corresponding position of TYDCs, we found a serine residue (S152) instead of A98, as reported by Torrens-Spence et al. [13]. This could account for the difference of the substrate specificity: the side chain of the substrate tyrosine is characterized by a hydroxyl group, and so the presence of a serine (side chain: –CH2OH) instead of an alanine (side chain: –CH3) into the binding site may be useful for substrate recognition and binding. The amino acid that precedes the motif II is F95, also involved in the interaction with ligands in our simulation of interaction with Trp and carbiDOPA–PLP. This residue is Phe or Tyr in TDCs, while it is always Tyr in position 149 of TYDCs, according to the alignment of sequences we reported in our previous study (see Supplementary Figure S5 in De Masi et al. [2]). The variability in position 95 of TDCs induced us to exclude it from the signature of motif II. A detailed investigation (not shown) of the interaction, schematically shown in Figure 3 and Figure 4, revealed that F95 interacts with ligands by means of its main chain atoms, thus suggesting a role that is not sidechain-specific. In our models, the other amino acids of the signature appeared not to be involved in the interaction with the ligands. Moreover, since this region emerged as FPATVSTAGF in our two Citrus sequences, this suggests that only the first half of the motif is relevant as a signature for TDCs.
The third segment previously observed in TDC is [H/Q]159[G/N]TTSE[A/S]ILCT (motif III), while in TYDC is Q219GT[T/A/S][C/S]EA[V/I]L[C/V][T/V]. Our docking results indicated that the central region T161TS in TDCs is involved in the interaction with ligands in the Citrus pTDC models (Figure 3 and Figure 4, and Supplementary Figure S7). While the first threonine is conserved also in all TYDCs, the other two amino acids in TYDCs are variable. This observation suggests a possible role of this region in the substrate specificity of TDCs and TYDCs. In this motif, we revealed a difference for glutamate (E) in the signature and aspartate (D) in the Citrus sequences, a conservative substitution that preserves the carboxylic group in the side chain.
It is particularly useful to note that a complex network of interactions involving numerous other amino acids was revealed by the docking simulations with Trp, carbiDOPA, and PLP in the Citrus pTDC models (Figure 3 and Figure 4, and Supplementary Figure S7). A total of nine amino acid residues are involved in the interaction with ligands: H198, T200, G255, T256, T257, D282, A284, Y285, and C323 (Table 1). These residues are not present in the putative signatures proposed in our previous work [2], being well conserved amino acids in both TDCs and TYDCs. Therefore, they appear not to be implied in substrate specificity, although their conservation during evolution evidences their importance in the interaction with ligands. To further confirm this, we observed that the C. roseus TDC docking with Trp (Supplementary Figure S8) showed the same conserved residues of the Citrus pTDC, as shown by the docking simulations in Figure 3 and Figure 4 and Supplementary Figures S7, S9, S10. Finally, it is interesting to note that H198 and D282 were already indicated to have a role in the catalytic mechanism as proton donor and in PLP stabilization, respectively [30]; the remaining seven amino acid residues, here identified as interacting with ligands, have not yet been experimentally investigated.
The fourth signature previously observed in TDC is S311PHKW (motif IV), corresponding to N371AHKW in TYDC. This region is known to be part of the PLP-binding domain [31]. The first two amino acids differ in TDCs and TYDCs, thus suggesting a possible role in substrate specificity, even if these two residues do not appear to be directly implied in the interaction with ligands. On the other hand, the imidazole side chain of histidine 313 (H313) appears to interact with the negatively charged phosphate group of PLP and carbiDOPA–PLP (Figure 3 and Figure 4 and Supplementary Figures S7, S9, S10). In addition to this, a key role is ascribed to lysine in position 314 (K314), which takes part in the interaction involving the positive charge of its ε-amino group and the negative charge of the carboxyl group of the Trp ligand (Figure 3, Supplementary Figures S7–S10). This interaction is not related to the side chain of Trp and, therefore, does not seem to be related to the specificity of substrate (i.e., Trp/Tyr preference). However, the presence of a P (proline) or A (alanine) two positions before this lysine may change significantly the backbone trace and the position of K314, because the structure of proline strongly restricts the allowed backbone conformations (Supplementary Figure S9). It is worth of note that the simulation of TDC interaction with Trp locates this ligand in close proximity of this segment, thus suggesting a role for substrate recognition, although more investigations are needed.
In conclusion, modeling and docking simulations allowed us to refine the definition of the amino acids involved in ligand binding sites and plant TDCs function. These interacting amino acids are remarkable, since part of the AADC family active site, whose microarchitecture provides the location where a specific type of substrate can be accepted. In addition, residues with functional groups in their side chains are of certain interest for their potential catalytic function. Therefore, this work provides important indications on which additional amino acid residues of TDCs have to be submitted to experimental analysis using site-directed mutagenesis to verify their real role in the catalytic mechanism. Further clarifications of the specific residues involved in Citrus TDC enzymatic reactions will certainly come from the determination of the enzyme 3D structure by X-ray crystallography. Taken all together, these characterized amino acids permit to hypothesize that the Citrus protein sequences studied are strong candidates for being homologous to TDC and functionally annotated for that enzymatic activity.

Supplementary Materials

The following are available online at https://www.mdpi.com/2218-273X/9/3/117/s1. Figure S1: Model of C. roseus TDC subunit; Figure S2: Model of pTDC subunit from clementine; Figure S3: Energy profile from PROSA Web of Template X-ray structure – PDB code: 3RBF; Figure S4: Energy profile from PROSA Web of C. roseus TDC; Figure S5: Energy profile from PROSA Web of sweet orange pTDC; Figure S6: Energy profile from PROSA Web of clementine pTDC; Figure S7: Docking simulations with the model of clementine pTDC; Figure S8: Docking simulation with the model of C. roseus TDC; Figure S9: 3D representation of ligand binding site in sweet orange pTDC; Figure S10: 3D representation of ligand binding site in clementine pTDC; Figure S11: Superposition of modeled sweet orange pTDC and template protein (human DDC, PDB code: 3RBF); Table S1: Quality checks for the models of TDC from C. roseus and pTDCs from Citrus by means of ProSA-Web.

Author Contributions

Conceptualization, A.F., D.P., L.S., D.C. and L.D.M.; Investigation, A.F., D.P., L.S., D.C. and L.D.M.; Methodology, A.F., D.P., L.S., D.C. and L.D.M.; Resources, L.S. and D.C.; Software, A.F., D.P. and L.D.M.; Supervision, L.S.; Writing—original draft, A.F. and L.D.M.; Writing—review & editing, A.F., D.P., L.S., D.C. and L.D.M.

Funding

This research received no external funding.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Pignone, D.; Hammer, K. Conservation, Evaluation, and Utilization of Biodiversity. In Genomics and Breeding for Climate-Resilient Crops, Vol. 1 Concepts and Strategies; Kole, C., Ed.; Springer: Berlin/Heidelberg, Germany, 2013; pp. 9–26. [Google Scholar]
  2. De Masi, L.; Castaldo, D.; Pignone, D.; Servillo, L.; Facchiano, A. Experimental evidence and in silico identification of tryptophan decarboxylase in Citrus genus. Molecules 2017, 22, 272. [Google Scholar] [CrossRef] [PubMed]
  3. Facchini, P.J.; Huber-Allanach, K.L.; Tari, L.W. Plant aromatic L-amino acid decarboxylases: Evolution, biochemistry, regulation, and metabolic engineering applications. Phytochemistry 2000, 54, 121–138. [Google Scholar] [CrossRef]
  4. Noé, W.; Mollenschott, C.; Berlin, J. Tryptophan decarboxylase from Catharanthus roseus cell suspension cultures: Purification, molecular and kinetic data of the homogenous protein. Plant Mol. Biol. 1984, 3, 281–288. [Google Scholar] [CrossRef] [PubMed]
  5. Bartley, G.E.; Breksa, A.P., 3rd; Ishida, B.K. PCR amplification and cloning of tyrosine decarboxylase involved in synephrine biosynthesis in Citrus. New Biotechnol. 2010, 27, 308–316. [Google Scholar] [CrossRef] [PubMed]
  6. Giardina, G.; Montioli, R.; Gianni, S.; Cellini, B.; Paiardini, A.; Voltattorni, C.B.; Cutruzzolà, F. Open conformation of human DOPA decarboxylase reveals the mechanism of PLP addition to Group II decarboxylases. Proc. Natl. Acad. Sci. USA 2011, 108, 20514–20519. [Google Scholar] [CrossRef]
  7. De Luca, V.; Marineau, C.; Brisson, N. Molecular cloning and analysis of cDNA encoding a plant tryptophan decarboxylase: Comparison with animal dopa decarboxylases. Proc. Natl. Acad. Sci. USA 1989, 86, 2582–2586. [Google Scholar] [CrossRef] [PubMed]
  8. Goddijn, O.J.; Lohman, F.P.; de Kam, R.J.; Schilperoort, R.A.; Hoge, J.H. Nucleotide sequence of the tryptophan decarboxylase gene of Catharanthus roseus and expression of tdc-gusA gene fusions in Nicotiana tabacum. Mol. Gen. Genet. 1994, 242, 217–225. [Google Scholar] [CrossRef]
  9. Khan, J.I.; Kennedy, T.J.; Christian, D.R., Jr. Tryptamines. In Basic Principles of Forensic Chemistry; Humana Press: Totowa, NJ, USA, 2012; Volume XXII, pp. 191–206. [Google Scholar]
  10. Burchett, S.A.; Hicks, T.P. The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain. Prog. Neurobiol. 2006, 79, 223–246. [Google Scholar] [CrossRef]
  11. Servillo, L.; Giovane, A.; Balestrieri, M.L.; Casale, R.; Cautela, D.; Castaldo, D. Citrus genus plants contain N-methylated tryptamine derivatives and their 5-hydroxylated forms. J. Agric. Food Chem. 2013, 61, 5156–5162. [Google Scholar] [CrossRef] [PubMed]
  12. Servillo, L.; Giovane, A.; D’Onofrio, N.; Casale, R.; Cautela, D.; Ferrari, G.; Balestrieri, M.L.; Castaldo, D. N-methylated derivatives of tyramine in Citrus genus plants: Identification of N,N,N-trimethyltyramine (candicine). J. Agric. Food Chem. 2014, 62, 2679–2684. [Google Scholar] [CrossRef] [PubMed]
  13. Torrens-Spence, M.P.; Lazear, M.; von Guggenberg, R.; Ding, H.; Li, J. Investigation of a substrate-specifying residue within Papaver somniferum and Catharanthus roseus aromatic amino acid decarboxylases. Phytochemistry 2014, 106, 37–43. [Google Scholar] [CrossRef]
  14. Alexander, F.W.; Sandmeier, E.; Mehta, P.K.; Christen, P. Evolutionary relationships among pyridoxal-5′-phosphate-dependent enzymes. Eur. J. Biochem. 1994, 219, 953–960. [Google Scholar] [CrossRef] [PubMed]
  15. Sandmeier, E.; Hale, T.I.; Christen, P. Multiple evolutionary origin of pyridoxal-5’-phosphate-dependent amino acid decarboxylases. Eur. J. Biochem. 1994, 221, 997–1002. [Google Scholar] [CrossRef] [PubMed]
  16. Grishin, N.V.; Phillips, M.A.; Goldsmith, E.J. Modeling of the spatial structure of eukaryotic ornithine decarboxylases. Protein Sci. 1995, 4, 1291–1304. [Google Scholar] [CrossRef]
  17. Schneider, G.; Käck, H.; Lindqvist, Y. The manifold of vitamin B6 dependent enzymes. Structure 2000, 8, R1–R6. [Google Scholar] [CrossRef]
  18. Burkhard, P.; Dominici, P.; Borri-Voltattorni, C.; Jansonius, J.N.; Malashkevich, V.N. Structural insight into Parkinson’s disease treatment from drug-inhibited DOPA decarboxylase. Nat. Struct. Biol. 2001, 8, 963–967. [Google Scholar] [CrossRef]
  19. Han, Q.; Ding, H.; Robinson, H.; Christensen, B.M.; Li, J. Crystal structure and substrate specificity of Drosophila 3,4-dihydroxyphenylalanine decarboxylase. PLoS ONE 2010, 5, e8826. [Google Scholar] [CrossRef] [PubMed]
  20. Marabotti, A.; Facchiano, A.M. Homology modeling studies on human galactose-1-phosphate uridylyltransferase and on its galactosemia -related mutant Q188R provide an explanation of molecular effects of the mutation on homo- and heterodimers. J. Med. Chem. 2005, 48, 773–779. [Google Scholar] [CrossRef]
  21. Salzano, M.; Marabotti, A.; Milanesi, L.; Facchiano, A. Human aryl-hydrocarbon receptor and its interaction with dioxin and physiological ligands investigated by molecular modelling and docking simulations. Biochem. Biophis. Res. Commun. 2011, 413, 176–181. [Google Scholar] [CrossRef]
  22. Brown, N.P.; Leroy, C.; Sander, C. MView: A web-compatible database search or multiple alignment viewer. Bioinformatics 1998, 14, 380–381. [Google Scholar] [CrossRef]
  23. Eswar, N.; Marti-Renom, M.A.; Webb, B.; Madhusudhan, M.S.; Eramian, D.; Shen, M.; Pieper, U.; Sali, A. Comparative Protein Structure Modeling with MODELLER. Current Protocols in Bioinformatics; John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2006. [Google Scholar]
  24. Laskowski, R.A.; MacArthur, M.W.; Moss, D.S.; Thornton, J.M. PROCHECK—A program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 1993, 26, 283–291. [Google Scholar] [CrossRef]
  25. Sippl, M.J. Recognition of errors in three-dimensional structures of proteins. Proteins 1993, 17, 355–362. [Google Scholar] [CrossRef] [PubMed]
  26. Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. Autodock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 16, 2785–2791. [Google Scholar] [CrossRef] [PubMed]
  27. Laskowski, R.A.; Swindells, M.B. LigPlot+: Multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 2011, 51, 2778–2786. [Google Scholar] [CrossRef] [PubMed]
  28. Facchiano, A. Bioinformatic resources for the investigation of proteins and proteomes. Peptidomics 2016, 2. [Google Scholar] [CrossRef]
  29. Sillitoe, I.; Cuff, A.L.; Dessailly, B.H.; Dawson, N.L.; Furnham, N.; Lee, D.; Lees, J.G.; Lewis, T.E.; Studer, R.A.; Rentzsch, R.; et al. New functional families (FunFams) in CATH to improve the mapping of conserved functional sites to 3D structures. Nucleic Acids Res. 2013, 41, D490–D498. [Google Scholar] [CrossRef]
  30. Ishii, S.; Mizuguchi, H.; Nishino, J.; Hayashi, H.; Kagamiyama, H. Functionally important residues of aromatic L-amino acid decarboxylase probed by sequence alignment and site-directed mutagenesis. J. Biochem. 1996, 120, 369–376. [Google Scholar] [CrossRef]
  31. Paiardini, A.; Giardina, G.; Rossignoli, G.; Voltattorni, C.B.; Bertoldi, M. New insights emerging from recent investigations on human group II pyridoxal 5′-phosphate decarboxylases. Curr. Med. Chem. 2017, 24, 226–244. [Google Scholar] [CrossRef]
Figure 1. Alignment of sweet orange and clementine putative tryptophan decarboxylases (pTDCs) with human l-DOPA decarboxylase (DDC), used as a template structure for the comparative modeling procedure. The image was adapted by the MView tool [22]. The background color indicates conserved residues, the color code indicates side-chain properties, i.e., green: hydrophobic, cyan: polar, yellow: cysteine, red: positive, blue: negative.
Figure 1. Alignment of sweet orange and clementine putative tryptophan decarboxylases (pTDCs) with human l-DOPA decarboxylase (DDC), used as a template structure for the comparative modeling procedure. The image was adapted by the MView tool [22]. The background color indicates conserved residues, the color code indicates side-chain properties, i.e., green: hydrophobic, cyan: polar, yellow: cysteine, red: positive, blue: negative.
Biomolecules 09 00117 g001
Figure 2. Model of the pTDC subunit from sweet orange. Protein architecture is evidenced by backbone schematization as a ribbon, larger for secondary-structure elements as helices and strands. The three domains are also indicated by colors: blue, N-terminal domain; green, central domain; red, C-terminal domain. The positions of the signature regions are also evidenced: motif I, yellow; II, light yellow; III, very light yellow; IV, white.
Figure 2. Model of the pTDC subunit from sweet orange. Protein architecture is evidenced by backbone schematization as a ribbon, larger for secondary-structure elements as helices and strands. The three domains are also indicated by colors: blue, N-terminal domain; green, central domain; red, C-terminal domain. The positions of the signature regions are also evidenced: motif I, yellow; II, light yellow; III, very light yellow; IV, white.
Biomolecules 09 00117 g002
Figure 3. Docking simulations using the model of sweet orange pTDC. The left scheme highlights the interactions with Trp ligand (a), the right scheme highlights the interactions with pyridoxal-5′-phosphate (PLP) ligand (b). A summary of the interactions is reported in Table 1.
Figure 3. Docking simulations using the model of sweet orange pTDC. The left scheme highlights the interactions with Trp ligand (a), the right scheme highlights the interactions with pyridoxal-5′-phosphate (PLP) ligand (b). A summary of the interactions is reported in Table 1.
Biomolecules 09 00117 g003
Figure 4. Docking simulation of the carbiDOPA–PLP adduct using the model of sweet orange pTDC. A summary of interactions is reported in Table 1.
Figure 4. Docking simulation of the carbiDOPA–PLP adduct using the model of sweet orange pTDC. A summary of interactions is reported in Table 1.
Biomolecules 09 00117 g004
Table 1. Plant TDC amino acids involved in the binding of ligands, according to the analysis of the docking simulations. TYDCs, l-tyrosine decarboxylases.
Table 1. Plant TDC amino acids involved in the binding of ligands, according to the analysis of the docking simulations. TYDCs, l-tyrosine decarboxylases.
Citrus pTDC Amino AcidMotif 1Interaction with Trp 2Interaction with PLP 3Interaction with carbiDOPA-PLP 4Corresponding Amino Acid in Catharanthus roseus TDC 5Corresponding Amino Acid in Plant TYDCs 6
W87I YesW92W141
F95 Yes YesF100Y149
F96II YesF101F/Y150
P97II YesP102P/A151
A98II YesA103S152
T161III YesYesT166T/S221
T162IIIYesYesYesT167T/A/G/S222
S163III YesS168C/S223
H198 YesYesYesH203H/L258
T200 YesYesM205A/S260
G255 Yes YesG260G315
T256 Yes T261T316
T257 YesYes T262T317
D282 YesYesYesD287D342
A284 YesYesYesA289A344
Y285 Yes Y290Y345
H313IV YesYesH318H373
K314IVYesYesYesK319K374
C323 Yes T328C/S383
1 The Latin numbering indicates the four motifs (I, II, III, IV) reported by De Masi et al. [2]. 2, 3 Interaction with Trp or PLP for sweet orange and clementine pTDC as graphically described in Figure 3 and Supplementary Figure S7, respectively. 4 Interaction with carbiDOPA–PLP for sweet orange pTDC as graphically described in Figure 4. 5 The amino acid numbering is according to sequence P17770. 6 The amino acid numbering is according to multiple sequence alignment reported in Supplementary Figure S5 of De Masi et al. (2017) [2].

Share and Cite

MDPI and ACS Style

Facchiano, A.; Pignone, D.; Servillo, L.; Castaldo, D.; De Masi, L. Structure and Ligands Interactions of Citrus Tryptophan Decarboxylase by Molecular Modeling and Docking Simulations. Biomolecules 2019, 9, 117. https://doi.org/10.3390/biom9030117

AMA Style

Facchiano A, Pignone D, Servillo L, Castaldo D, De Masi L. Structure and Ligands Interactions of Citrus Tryptophan Decarboxylase by Molecular Modeling and Docking Simulations. Biomolecules. 2019; 9(3):117. https://doi.org/10.3390/biom9030117

Chicago/Turabian Style

Facchiano, Angelo, Domenico Pignone, Luigi Servillo, Domenico Castaldo, and Luigi De Masi. 2019. "Structure and Ligands Interactions of Citrus Tryptophan Decarboxylase by Molecular Modeling and Docking Simulations" Biomolecules 9, no. 3: 117. https://doi.org/10.3390/biom9030117

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop